Camilla Wiuff
- Molecular Medicine top 0.5%
- Infectious Diseases top 2%
- Epidemiology top 10%
- Molecular Biology
- Pharmacology top 5%
- Co-authors
- Frank M. AarestrupRoland R. RegoesBruce R. LevinFernando BaqueroE. John ThrelfallKåre MølbakEvelyn BalsellsMoe H. Kyaw
- Topics
- Clostridium difficile and Clostridium perfringens research (13 papers)Microscopic Colitis (9 papers)Antibiotic Resistance in Bacteria (8 papers)
- Journals
- Antimicrobial Agents and ChemotherapyThe Lancet Infectious DiseasesJournal of Antimicrobial Chemotherapy
- Partner nations
- United KingdomDenmarkUnited States
In The Last Decade
Camilla Wiuff
34 papers receiving 1.6k citations
Peers
Comparison fields: 5 of 95
- Molecular Medicine 635
- Infectious Diseases 616
- Epidemiology 459
- Molecular Biology 288
- Pharmacology 273
Countries citing papers authored by Camilla Wiuff
This map shows the geographic impact of Camilla Wiuff's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Camilla Wiuff with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Camilla Wiuff more than expected).
Fields of papers citing papers by Camilla Wiuff
This network shows the impact of papers produced by Camilla Wiuff. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Camilla Wiuff. The network helps show where Camilla Wiuff may publish in the future.
Co-authorship network of co-authors of Camilla Wiuff
This figure shows the co-authorship network connecting the top 25 collaborators of Camilla Wiuff. A scholar is included among the top collaborators of Camilla Wiuff based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Camilla Wiuff. Camilla Wiuff is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 10 | |
| 2 | 222 | |
| 3 | 13 | |
| 4 | 83 | |
| 5 | 15 | |
| 6 | 19 | |
| 7 | 9 | |
| 8 | 10 | |
| 9 | 17 | |
| 10 | 17 | |
| 11 | 3 | |
| 12 | 45 | |
| 13 | 21 | |
| 14 | 76 | |
| 15 | 235 | |
| 16 | 63 | |
| 17 | 53 | |
| 18 | 42 | |
| 19 | 15 | |
| 20 | 14 |
About Camilla Wiuff
Camilla Wiuff is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine and Critical Care and Intensive Care Medicine, having authored 34 papers that have together received 1.6k indexed citations. Recurring topics across this work include Clostridium difficile and Clostridium perfringens research (13 papers), Microscopic Colitis (9 papers) and Antibiotic Resistance in Bacteria (8 papers). The work is most often cited by research in Molecular Medicine (635 citations), Applied Microbiology and Biotechnology (145 citations) and Endocrinology (228 citations). Camilla Wiuff has collaborated with scholars based in United Kingdom, Denmark and United States. Frequent co-authors include Frank M. Aarestrup, Roland R. Regoes, Bruce R. Levin, Fernando Baquero, E. John Threlfall, Kåre Mølbak, Evelyn Balsells, Moe H. Kyaw, Harish Nair and Ole Lander Svendsen. Their work appears in journals such as Antimicrobial Agents and Chemotherapy, The Lancet Infectious Diseases and Journal of Antimicrobial Chemotherapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.